Eiko Lifesciences Ltd
₹ 49.2
-0.34%
10 Jul
- close price
About
Incorporated in 2021, Eiko LifeSciences
Ltd manufacturing & sells Specialty
Chemical and Fine Chemicals[1]
Key Points
- Market Cap ₹ 70.6 Cr.
- Current Price ₹ 49.2
- High / Low ₹ 64.4 / 45.9
- Stock P/E 19.7
- Book Value ₹ 47.0
- Dividend Yield 0.00 %
- ROCE 7.65 %
- ROE 5.78 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 1.05 times its book value
- Company is expected to give good quarter
- Promoter holding has increased by 2.74% over last quarter.
- Company's working capital requirements have reduced from 155 days to 89.8 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 39.9%
- Company has a low return on equity of 3.73% over last 3 years.
- Earnings include an other income of Rs.2.13 Cr.
- Company has high debtors of 164 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.11 | 0.58 | 0.40 | 0.51 | 0.39 | 0.00 | 11.99 | 25.41 | 18.32 | 27.93 | 32.49 | 42.13 | |
| 0.08 | 0.47 | 0.14 | 0.18 | 0.20 | 0.17 | 11.47 | 24.10 | 17.35 | 26.31 | 30.78 | 38.80 | |
| Operating Profit | 0.03 | 0.11 | 0.26 | 0.33 | 0.19 | -0.17 | 0.52 | 1.31 | 0.97 | 1.62 | 1.71 | 3.33 |
| OPM % | 27.27% | 18.97% | 65.00% | 64.71% | 48.72% | 4.34% | 5.16% | 5.29% | 5.80% | 5.26% | 7.90% | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.43 | 0.46 | 0.67 | 0.85 | 0.18 | 1.37 | 2.13 | |
| Interest | 0.00 | 0.00 | 0.02 | 0.05 | 0.03 | 0.07 | 0.09 | 0.48 | 0.16 | 0.15 | 0.13 | 0.16 |
| Depreciation | 0.00 | 0.00 | 0.02 | 0.06 | 0.06 | 0.06 | 0.06 | 0.56 | 0.63 | 0.66 | 0.63 | 0.59 |
| Profit before tax | 0.03 | 0.11 | 0.22 | 0.22 | 0.10 | 0.13 | 0.83 | 0.94 | 1.03 | 0.99 | 2.32 | 4.71 |
| Tax % | 33.33% | 27.27% | 27.27% | 13.64% | 30.00% | 0.00% | 26.51% | 24.47% | 25.24% | 23.23% | 24.57% | 23.99% |
| 0.02 | 0.08 | 0.17 | 0.18 | 0.07 | 0.13 | 0.61 | 0.71 | 0.77 | 0.75 | 1.74 | 3.58 | |
| EPS in Rs | 0.04 | 0.16 | 0.34 | 0.28 | 0.11 | 0.20 | 0.95 | 0.51 | 0.55 | 0.64 | 1.40 | 2.50 |
| Dividend Payout % | 0.00% | 0.00% | 44.41% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 54% |
| 5 Years: | 29% |
| 3 Years: | 32% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 46% |
| 5 Years: | 42% |
| 3 Years: | 68% |
| TTM: | 144% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -5% |
| 3 Years: | -4% |
| 1 Year: | -12% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 4% |
| 3 Years: | 4% |
| Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.02 | 3.02 | 3.02 | 3.82 | 3.82 | 3.82 | 3.82 | 8.32 | 8.32 | 12.87 | 13.76 | 14.35 |
| Reserves | 0.02 | 0.10 | 0.21 | 1.73 | 1.61 | 1.66 | 8.71 | 20.31 | 21.11 | 37.81 | 42.66 | 53.15 |
| 0.00 | 0.25 | 0.41 | 0.37 | 0.31 | 0.26 | 1.83 | 4.63 | 0.05 | 0.00 | 1.75 | 1.67 | |
| 0.01 | 0.02 | 0.12 | 0.06 | 0.02 | 0.02 | 2.25 | 1.64 | 1.57 | 2.06 | 2.21 | 13.62 | |
| Total Liabilities | 3.05 | 3.39 | 3.76 | 5.98 | 5.76 | 5.76 | 16.61 | 34.90 | 31.05 | 52.74 | 60.38 | 82.79 |
| 0.00 | 0.00 | 0.49 | 0.43 | 0.37 | 0.31 | 0.25 | 14.29 | 13.88 | 13.57 | 14.26 | 13.67 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.26 | 2.59 | 2.45 | 3.58 | 2.13 | 0.50 | 0.22 | 0.20 | 0.05 | 4.02 | 7.07 | 15.15 |
| 2.79 | 0.80 | 0.82 | 1.97 | 3.26 | 4.95 | 16.14 | 20.41 | 17.12 | 35.15 | 39.05 | 53.97 | |
| Total Assets | 3.05 | 3.39 | 3.76 | 5.98 | 5.76 | 5.76 | 16.61 | 34.90 | 31.05 | 52.74 | 60.38 | 82.79 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.05 | 0.19 | 0.19 | 0.24 | -0.19 | 0.77 | -0.83 | -7.73 | 4.22 | -7.08 | 2.05 | ||
| -2.75 | 0.05 | -0.38 | -1.33 | -0.43 | -0.65 | -2.94 | 0.59 | 0.87 | -0.55 | -9.85 | ||
| 2.80 | 0.25 | 0.15 | 1.82 | -0.08 | -0.13 | 7.81 | 3.28 | -4.70 | 20.36 | 5.97 | ||
| Net Cash Flow | 0.01 | 0.49 | -0.04 | 0.72 | -0.71 | -0.01 | 4.05 | -3.85 | 0.40 | 12.73 | -1.83 | |
| Free Cash Flow | -0.05 | 0.19 | -0.33 | 0.24 | -0.19 | 0.77 | -0.83 | -7.88 | 4.00 | -7.43 | 0.72 | |
| CFO/OP | -133% | 191% | 96% | 85% | -84% | -459% | -125% | -574% | 427% | -435% | 137% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 331.82 | 0.00 | 0.00 | 0.00 | 74.87 | 103.81 | 65.50 | 141.66 | 171.59 | 113.92 | 163.66 | |
| Inventory Days | 2.06 | 88.26 | 20.64 | 48.70 | 50.23 | 38.86 | ||||||
| Days Payable | 65.30 | 21.82 | 23.82 | 19.82 | 13.87 | 121.67 | ||||||
| Cash Conversion Cycle | 331.82 | 0.00 | 0.00 | 0.00 | 74.87 | 40.57 | 131.94 | 138.48 | 200.46 | 150.28 | 80.85 | |
| Working Capital Days | 298.64 | 12.59 | 127.75 | 200.39 | 561.54 | 133.34 | 89.20 | 149.23 | 210.14 | 164.47 | 89.84 | |
| ROCE % | 1.84% | 3.43% | 6.85% | 5.65% | 2.23% | 3.48% | 9.15% | 5.88% | 3.70% | 2.84% | 3.84% | 7.65% |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Export Revenue Share % |
|
||||
| Number of Permanent Employees count |
|||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
- Closure of Trading Window 24 Jun
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
27 May - Newspaper publication dated 27th May, 2026 for Audited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Year ended 31st March, 2026 …
-
Announcement under Regulation 30 (LODR)-Change in Management
26 May - M/s NP Rajput & Co appointed internal auditor for FY 2026-27 on 26 May 2026.
-
Board Meeting Outcome for Outcome Of The Board Meeting
26 May - Board approved audited FY26 results; standalone profit Rs358.11 lakh, consolidated profit Rs532.47 lakh; appointed internal auditor for FY27.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
25 May - Filed annual secretarial compliance report for FY2026; SEBI levied Rs.1 lakh penalty on promoter entity.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Business Overview:[1]
ELL is in the business of manufacturing, processing, formulating, producing, buying, selling, and exporting specialty and Fine Chemicals comprising organic & inorganic chemicals, and Pharma Intermediates, etc.